|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 17736841.2 (espacenet) (Federated) (European Patent Register), 20170623 | | Patent/reg. no. and date | DK/EP 3478712, 20230719 | | Publication date | 20190508 | | Priority no. and date | US 201662357579 P, 20160701 | | EP pub. no. and date |
EP 3478712 20190508 | | Effective date | | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | | Applicant ref. no. | V462004DK00 | | Inventor | DEMATTOS, Ronald Bradley, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis
Indiana 46206-6288, US,
IRIZARRY, Michael Carl, c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis
Indiana 46206-6288, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 25/28 (2006.01) , C07K 16/18 (2006.01) | | Title | Anti-N3pGlu-amyloidbetapeptid-antistoffer og anvendelser deraf | | Int. application no. | US2017038999 | | Int. publication no. | WO2018005282 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
